In early 2026, Alphatec Holdings tightened its revenue recognition practices concerning contract assets and liabilities reflecting staged performance obligations, signaling improved top-line clarity. The company also secured a senior secured credit agreement with JPMorgan Chase to enhance liquidity and flexibility. These financial moves underpin ongoing investments in an exclusive, clinically savvy salesforce aimed at broadening market penetration. Alphatec’s concentrated spine device portfolio integrated with its InformatiX platform positions it well within a competitive yet specialized spine surgery segment poised for structural growth.